Major outer membrane proteins from many Campylobacter species cross-react with cholera toxin

Clinical and Vaccine Immunology

Volumn 15, Issue 5, 2008, Pages 859-862

  Albert, M John ^a   Haridas, Shilpa ^a   Adler, Ben ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; PORIN A; OUTER MEMBRANE PROTEIN;

ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL INFECTION; CAMPYLOBACTER COLI; CAMPYLOBACTER FETUS; CAMPYLOBACTER HYOINTESTINALIS; CAMPYLOBACTER LARI; CAMPYLOBACTER UPSALIENSIS; CROSS REACTION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; WESTERN BLOTTING; ANIMAL; CAMPYLOBACTER; CHEMISTRY; HAMSTER; IMMUNOLOGY; ISOLATION AND PURIFICATION;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; CAMPYLOBACTER; CHOLERA TOXIN; CRICETINAE; CROSS REACTIONS;

EID: 46249133096     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00471-07     Document Type: Article

References (29)

1. Albert, M. J., S. Haridas, D. Steer, G. S. Dhaunsi, A. I. Smith, and B. Adler. 2007. Identification of a Campylobacter jejuni protein that cross-reacts with cholera toxin. Infect. Immun. 75:3070-3073.
2. Allos, B. M., and M. J. Blaser. 1995. Campylobacter jejuni and expanding spectrum of related infections. Clin. Infect. Dis. 20:1092-1099.
3. Black, R. E., M. M. Levine, M. L. Clements, T. P. Hughes, and M. J. Blaser. 1988. Experimental Campylobacter jejuni infection in humans. J. Infect. Dis. 157:472-479.
4. Blaser, M. J., J. A. Hopkins, R. M. Berka, M. L. Vasil, and W.-L. L. Wang. 1983. Identification and characterization of Campylobacter jejuni outer membrane proteins. Infect. Immun. 42:276-284.
5. Blaser, M. J., P. F. Smith, J. A. Hopkins, I. Heinzer, J. H. Bryner, and W. L. Wang. 1987. Pathogenesis of Campylobacter fetus infections: serum resistance associated with high-molecular-weight surface proteins. J. Infect. Dis. 155:696-706.
6. Bok, H. E., A. S. Greeff, and H. H. Crewe-Brown. 1991. Incidence of toxigenic Campylobacter strains in South Africa. J. Clin. Microbiol. 29:1262-1264.
7. Brown, P. E., O. F. Christensen, H. E. Clough, P. J. Diggle, C. A. Hart, S. Hazel, R. Kemp, A. J. Leatherbarrow, A. Moore, J. Sutherst, J. Turner, N. J. Williams, E. J. Wright, and N. P. French. 2004. Frequency and spatial distribution of environmental Campylobacter spp. Appl. Environ. Microbiol. 70:6501-6511.
8. Everest, P. H., H. Goossens, J.-P. Butzler, D. Lloyd, S. Knutton, J. M. Ketley, and P. H. Williams. 1992. Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli. J. Med. Microbiol. 37:319-325.
9. Goossens, H., J.-P. Butzler, and Y. Takeda. 1985. Demonstration of cholera-like enterotoxin production by Campylobacter jejuni. FEMS Microbiol. Lett. 29:73-76.
10. Hum, S., K. Quinn, J. Brunner, and S. L. W. On. 1997. Evaluation of a PCR assay for identification and differentiation of Campylobacter fetus subspecies. Aust. Vet. J. 75:827-831.
11. Johnson, W. M., and H. Lior. 1986. Cytotoxic and cytotonic factors produced by Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis. J. Clin. Microbiol. 24:275-281.
12. Johnson, W. M., and H. Lior. 1988. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb. Pathog. 4:115-126.
13. Ketley, J. M. 1997. Pathogenesis of enteric infection by Campylobacter. Microbiology 143:5-21.
14. Khan, I., B. Adler, S. Haridas, and M. J. Albert. 2005. PorA protein of Campylobacter jejuni is not a cytotoxin mediating inflammatory diarrhoea. Microb. Infect. 7:853-859.
15. Klena, J. D., C. T. Parker, K. Knibb, J. C. Ibbitt, P. M. L. Devane, S. T. Horn, W. G. Miller, and M. E. Konkel. 2004. Differentiation of Campylobacter coli, Campylobacter jejuni, Campylobacter lari, and Campylobacter upsaliensis by a multiplex PCR developed from the nucleotide sequence of the lipid gene lpxA. J. Clin. Microbiol. 42:5549-5557.
16. Klipstein, F. A., and R. F. Engert. 1985. Immunological relationship of the B subunits of Campylobacter jejuni and Escherichia coli heat-labile enterotoxins. Infect. Immun. 48:629-633.
17. Konkel, M. E., Y. Lobet, and W. Cieplak. 1992. Examination of multiple isolates of Campylobacter jejuni for evidence of cholera toxin-like activity, p. 193-198. In I. Nachamkin, M. J. Blaser, and L. S. Tomkins (ed.), Campylobacter jejuni: current status and future trends. American Society for Microbiology, Washington, DC.
18. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
19. Lindblom, G.-B., M. Johny, K. Khalil, K. Mazhar, G. M. Ruiz-Palacios, and B. Kaijser. 1990. Enterotoxigenicity and frequency of Campylobacter jejuni, Campylobacter coli and Campylobacter laridis in human and animal stool isolates from different countries. FEMS Microbiol. Lett. 54:163-168.
20. McCardell, B. A., J. M. Madden, and J. T. Stanfield. 1986. Effect of iron concentration on toxin production in Campylobacter jejuni and C. coli. Can. J. Microbiol. 32:395-401.
21. Mills, S. D., and W. C. Bradbury. 1984. Human antibody response to outer membrane proteins of Campylobacter jejuni during infection. Infect. Immun. 43:739-743.
22. Nachamkin, I. 1999. Campylobacter and Arcobacter, p. 716-726. In P. R. Murray, E. J. Barron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, DC.
23. Nachamkin, I., and A. M. Hart. 1985. Western blot analysis of the human antibody response to Campylobacter jejuni cellular antigens during gastrointestinal infection. J. Clin. Microbiol. 21:33-38.
24. Olsvik, Ø., K. Wachsmuth, G. Morris, and J. C. Feeley. 1984. Genetic probing of Campylobacter jejuni for cholera toxin and E. coli heat-labile enterotoxin. Lancet i:449.
25. Perez-Perez, G. I., D. L. Cohn, R. L. Guerrant, C. M. Patton, L. B. Reller, and M. J. Blaser. 1989. Clinical and immunological significance of cholera-like toxin and cytotoxin production by Campylobacter species in patients with acute inflammatory diarrhea in the USA. J. Infect. Dis. 160:460-468.
26. Perez-Perez, G. I., D. N. Taylor, P. D. Echeverria, and M. J. Blaser. 1992. Lack of evidence of enterotoxin involvement in pathogenesis of Campylobacter diarrhea, p. 184-192. In I. Nachamkin, M. J. Blaser, and L. S. Tomkins (ed.), Campylobacter jejuni: current status and future trends. American Society for Microbiology, Washington, DC.
27. Ruiz-Palacios, G. M., N. I. Torres, B. R. Ruiz-Palacios, J. Torres, E. Escamilla, and J. Tamayo. 1983. Cholera-like enterotoxin produced by Campylobacter jejuni: characterisation and clinical significance. Lancet ii:250-253.
28. Wadstrom, T. S., S. B. Baloda, K. Krovacek, A. Faris, S. Bengtson, and M. Walder. 1983. Swedish isolates of Campylobacter jejuni/coli do not produce cytotonic or cytotoxic enterotoxins. Lancet ii:911.
29. Wassenaar, T. M. 1997. Toxin production by Campylobacter spp. Clin. Microbiol. Rev. 10:466-476.